Mereo BioPharma Group (MREO) Change in Account Payables: 2023-2025
Historic Change in Account Payables for Mereo BioPharma Group (MREO) over the last 3 years, with Sep 2025 value amounting to -$236,000.
- Mereo BioPharma Group's Change in Account Payables rose 77.84% to -$236,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$982,000, marking a year-over-year decrease of 438.62%. This contributed to the annual value of $146,000 for FY2024, which is 111.56% up from last year.
- According to the latest figures from Q3 2025, Mereo BioPharma Group's Change in Account Payables is -$236,000, which was up 87.90% from -$2.0 million recorded in Q2 2025.
- Mereo BioPharma Group's Change in Account Payables' 5-year high stood at $987,000 during Q4 2023, with a 5-year trough of -$2.3 million in Q2 2023.
- In the last 3 years, Mereo BioPharma Group's Change in Account Payables had a median value of $127,000 in 2024 and averaged -$267,455.
- Within the past 5 years, the most significant YoY rise in Mereo BioPharma Group's Change in Account Payables was 185.04% (2025), while the steepest drop was 909.54% (2025).
- Over the past 3 years, Mereo BioPharma Group's Change in Account Payables (Quarterly) stood at $987,000 in 2023, then decreased by 14.59% to $843,000 in 2024, then surged by 77.84% to -$236,000 in 2025.
- Its last three reported values are -$236,000 in Q3 2025, -$2.0 million for Q2 2025, and $362,000 during Q1 2025.